HASSAN EMIL E 4

What Happened Emil E. Hassan, a director of National Healthcare Corp (NHC), received a grant of 7,500 stock options on May 7, 2026. The Form 4 lists the acquisition as a derivative award at $0.00 (no cash exchanged at grant); the reported immediate value is $0. This is an award/option grant (transaction code A), not an open‑market purchase or sale.

Key Details

• Transaction date: 2026-05-07; transaction type: Grant/Award (code A).
• Amount: 7,500 shares shown as derivative securities at $0.00 on the Form 4.
• Shares owned following the transaction: not disclosed in this filing.
• Footnote: Options were granted under the 2020 Omnibus Equity Incentive Plan; grant and exercise are exempt from Section 16(b) under Rule 16b-3(d).
• Filing timeliness: Period of report equals transaction date (filed 2026-05-07); no late filing indicated.

Context This filing reports a grant of stock options (a derivative award). Grants do not represent immediate sales or purchases of common stock — value to the insider depends on vesting, the option strike price, and future stock performance. The Rule 16b-3(d) exemption is a standard provision that allows certain company-approved equity awards to insiders without exposure to short-swing profit liability.